Merrill, Joan T.
Article History
First Online: 5 May 2015
Competing interests
: J.T.M. declares that she has acted as a consulted for Amgen, Anthera, Bristol-Myers Squibb, EMD Serono, GlaxoSmithKline, Genentech, Lilly, MedImmune, Pfizer and UCB, companies that have developed or are developing biologic treatments for lupus that are either mentioned or have overlapping mechanisms of action with the products mentioned in this commentary. J.T.M. also declares that she has received research grants from Bristol-Myers Squibb, Genentech and GlaxoSmithKline and speaker's honoraria from GlaxoSmithKline.